会社案内

What we do

We assist healthcare businesses in developing their growth strategies in Asia-Pacific, adapting them to the changing dynamics in the marketplace, and building the business cases for investments. We help life science companies plan, accelerate, and manage their growth.

Market Opportunity Assessment:
Whether you are considering a regional market opportunity assessment or a limited end-user survey, it is important to take the appropriate market research approach. We use a combination of primary and secondary market data collection, focus groups and expert face-to-face interviews in conducting analyses and benchmarking of manufacturers, distributors and global/local competitors. We conduct interviews with key opinion leaders in all major Asian languages.
Market Entry Strategy:
With limited resources, companies must identify the markets capable of providing the quickest returns. We can help you assess market attractiveness and establish market entry priorities according to the economic and socio-political factors affecting the market, local regulatory requirements, distribution channels and competition. Following in-depth research, we will develop, recommend and implement entry strategies to meet your objectives.
Distributor and Channel Management:
Distribution of medical products is more challenging than ever and determining how best to structure the sales channels of your product is crucial. We can advise you on which channels of distribution will be most successful, conduct feasibility studies for direct sales operations and identify and assess potential distributors. We can also audit, manage and monitor your distributors to agreed performance and cost criteria. Our Channel-Mapping™ methodology is a proprietary tool providing objective distributor assessment and benchmarking. Our in-house database contains the detailed profiles of hundreds of distributors with whom we already have established personal relationships.
Strategy Development:
Based on a rigorous analysis of market dynamics and company capabilities we can objectively identify and evaluate your available strategic options. We conduct organizational reviews and full strategic planning reviews on a global or regional basis. Leveraging on relationships with experienced companies can be a major factor in easing your entry into a new market and determining success.
Partnerships, JV's, Mergers and Acquisitions:
We assist in identifying and evaluating potential R&D partners, partners for licensing agreements, and technology transfer and strategic alliances. We can also help potential acquirers with commercial, technical and regulatory due diligence to investigate in detail the target candidate's market and financial standing. We identify and evaluate potential alliance partners and contract manufacturers and undertake due diligence in respect of acquisitions.
Strategic Sourcing and Contract Manufacturing:
We assist clients in their strategic sourcing initiatives from determining the optimal sourcing approach to identifying and evaluating component suppliers and contract manufacturing partners with particular focus on China, Taiwan, India, Singapore and Malaysia. Our work with past clients has involved a broad range of outsourced technologies and processes including injection molding, extrusion, CNC machining, PCBA manufacturing and box build assembly. We also can help you establish local manufacturing operations and obtain local government grants and incentives.
Advisory Services for Investors:
We assist private equity investors to better evaluate and manage investments in the life science sector. We provide investors in Asia-Pacific access to very high quality deal flows from the United States, Canada, Europe and Israel. We conduct market due diligence and assist in Term Sheet negotiations. In addition, we provide a full range of commercialization and business development services for life science companies within existing venture capital portfolios.
Services for Entrepreneurs and Emerging Growth Companies:
We assist emerging growth companies in raising capital in Asia from private groups, high-net-worth individuals, government, venture capital firms and other institutional equity providers. Our investor network encompasses Singapore, Malaysia, Hong Kong, Taiwan, Japan and Australia.
Investors often need help in understanding how a new technology or clinical application can translate into shareholder value. We can clarify your compelling value propositions for investors and help you develop a powerful Business Plan including review of revenue models, generation and selection of strategic options, exit strategies, financial forecasts and sensitivity analysis.
Through our strategic industry networks we can suggest sales alliances and business partnerships that will accelerate your establishment in the market. We also offer practical management services in establishing an Asian subsidiary, building effective local management teams and setting up Medical Advisory Boards.
Regulatory Affairs:
Most market entry strategies in Asia-Pacific need to go hand-in-hand with an appropriate regulatory approach. We provide the necessary roadmaps advising our clients on how to best navigate the local regulatory environment -- whether you need help addressing the requirements of China's SFDA or Singapore's HSA or simply better understand the strategic implications of Japan's new Market Authorization Holder system. We also assess the regulatory capabilities of distributors and provide services in clinical trial management.

SSL グローバルサインのサイトシール

SSLとは?